Searchable abstracts of presentations at key conferences in endocrinology

ea0029p70 | Adrenal cortex | ICEECE2012

Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage

Benso A. , Lucatello B. , Capello E. , Marafetti L. , Tabaro I. , Caprino M Parasiliti , Ghigo E. , Maccario M.

Background: Data on the prevalence of primary aldosteronism (PA) in subjects with resistant hypertension (inadequate pressure control with three full-dose drugs, including a diuretic) are scanty and it is not known if PA is associated with a more severe vascular damage.Aim: To determine the prevalence of PA in patients with resistant hypertension and define the possible association with early cardiovascular damage.Methods: Seventy ...

ea0011p897 | Thyroid | ECE2006

The GH response to ghrelin in humans is reduced in conditions of hyper- and hypothyroidism

Broglio F , Prodam F , Riganti F , Gramaglia E , Rossetto R , Maccario M , Ghigo E

Both hyper- and hypothyroidism show reduced spontaneous and GHRH-stimulated GH secretion. Although impaired GHRH secretion and activity as well as reduced GH pituitary synthesis have been reported in these pathological conditions, a definitive description of the underlying pathophysiological mechanisms have not been provided yet. Ghrelin elicits a potent GH-releasing effect partially mediated by a functional somatostatin antagonism and a synergic interaction with GHRH. Moreove...

ea0029p73 | Adrenal cortex | ICEECE2012

Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors

Lucatello B. , Benso A. , Tabaro I. , Capello E. , Marafetti L. , Caprino M Parasiliti , Rossato D. , Oleandri S. , Ghigo E. , Maccario M.

Background: Idiopathic primary hyperaldosteronism (IHA) is the subtype of primary aldosteronism (PA) in which lateralization of the mineralocorticoid hypersecretion cannot be demonstrated. Scanty data are available on the clinical history of IHA: a couple of brief reports suggest a remission of aldosterone hypersecretion after years of treatment with mineralocorticoid receptor blocking agents.Aim of this study was to check the persistence/remission of al...

ea0029p1387 | Pituitary Clinical | ICEECE2012

Surveillance study on the prevalence of manifestations, complications and illness associated to acromegaly

Guaraldi F. , Maccario M. , Prencipe N. , Di Giacomo S. , Gasco V. , Berton A. , Mainolfi A. , Ghigo E. , Grottoli S.

Introduction: Acromegaly is a rare disease caused by chronic exposure to excessive levels of GH, usually related to the presence of a pituitary adenoma, and associated to somatic and visceral hypertrophy, metabolic alterations, respiratory and cardiovascular complications, and increased risk of neoplasias.Materials and methods: The prevalence of manifestations, complications and associated illness was evaluated in 137 acromegalic subjects (52 M, 85 F; ag...

ea0029p1447 | Pituitary Clinical | ICEECE2012

Acylated ghrelin as provocative test for the diagnosis of gh deficiency in adults

Gasco V. , Beccuti G. , Baldini C. , Prencipe N. , Guaraldi F. , Di Giacomo S. , Berton A. , Maccario M. , Ghigo E. , Grottoli S.

ITT is the test of reference for the diagnosis of adult GH deficiency (GHD), but also GHRH in combination with arginine (ARG) or GH secretagogues (GHS) are considered equally reliable tests. Testing with GHS alone is, anyway, a potent stimulus exploring the integrity of hypothalamic pathways controlling somatotropic function.We therefore aimed to clarify the diagnostic reliability of testing with ghrelin, the natural GHS.We studied...

ea0083ao1 | Adrenal and Cardiovascular | EYES2022

Steroidomic approach for the characterization of patients with non-alcoholic fatty liver disease

M Parasiliti-Caprino , C Rosso , F Ponzetto , P Caviglia G. , C Lopez , A Armandi , G. M. Saracco , E Ghigo , E Bugianesi , M Maccario

Introduction: The onset and progression of liver damage in non-alcoholic fatty liver disease (NAFLD) is tightly associated with metabolic derangements. Steroids may affect lipid metabolism but their alterations in the setting of NAFLD remain to be fully explored.Patients and Methods: We analyzed data from 267 patients with biopsy-proven NAFLD and 112 controls (CT). A panel of 26 steroids (including glucocorticoids, mineralocorticoids, androgens, and prog...